These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 6143962)
21. [Detection of specific antibodies for HTLV in French blood donors]. Schaffar-Deshayes L; Couroucé AM; Monplaisir N; Chavance M; Lévy JP Rev Fr Transfus Immunohematol; 1984 Sep; 27(4):509-11. PubMed ID: 6095411 [TBL] [Abstract][Full Text] [Related]
22. Antibodies to AIDS and heated factor VIII. Mannucci PM; Gringeri A; Ammassari M Lancet; 1985 Jun; 1(8444):1505-6. PubMed ID: 2861430 [No Abstract] [Full Text] [Related]
23. [Preventive measures against HTLV-III/LAV infections among hemophiliacs and their relatives]. Evensen SA; Frøland SS; Glomstein A Tidsskr Nor Laegeforen; 1986 Jan; 106(1):19-21. PubMed ID: 3006278 [No Abstract] [Full Text] [Related]
24. HTLV-III/LAV-seronegative, virus-negative sexual partners and household contacts of hemophiliacs. McFadden T; Jason JM; Feorino P JAMA; 1986 Apr; 255(13):1702. PubMed ID: 3005673 [No Abstract] [Full Text] [Related]
25. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS. Chorba TL; Jason JM; Ramsey RB; Lechner K; Pabinger-Fasching I; Kalyanaraman VS; McDougal JS; Cabradilla CD; Tregillus LC; Lawrence DN Thromb Haemost; 1985 Apr; 53(2):180-2. PubMed ID: 2992112 [TBL] [Abstract][Full Text] [Related]
26. Absence of seroconversion for HTLV-III in haemophiliacs intensively treated with heat treated factor VIII concentrate. van der Meer J; Daenen S; van Imhoff GW; de Wolf JT; Halie MR Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1049. PubMed ID: 3008906 [No Abstract] [Full Text] [Related]
27. Predictive value of a screening test for antibodies to HTLV-III. Sivak SL; Wormser GP Am J Clin Pathol; 1986 Jun; 85(6):700-3. PubMed ID: 3010700 [TBL] [Abstract][Full Text] [Related]
28. HTLV-III seropositivity in symptom-free Italian haemophiliacs. Correlation with consumption of commercial concentrate and abnormalities of T and B lymphocytes. Giudizi MG; Biagiotti R; Almerigogna F; Mazzetti M; Alessi A; Massai G; Longo G; Scano G; Morfini M; Romagnani S Scand J Haematol; 1986 Feb; 36(2):198-202. PubMed ID: 2422735 [TBL] [Abstract][Full Text] [Related]
29. One year follow-up study of T-cell subsets and incidence of seropositivity for HTLV-I and HTLV-III antibodies in patients treated "on demand" or sporadically with clotting concentrates. Rodeghiero F; Castaman GC; Chisesi T; De Rossi A; Dalla Gassa O; Del Mistro A; Dini E; Castronovo S; Pornaro E; Chieco-Bianchi L Thromb Haemost; 1985 Oct; 54(3):665-8. PubMed ID: 3003954 [TBL] [Abstract][Full Text] [Related]
31. Development and early natural history of HTLV-III antibodies in persons with hemophilia. Eyster ME; Goedert JJ; Sarngadharan MG; Weiss SH; Gallo RC; Blattner WA JAMA; 1985 Apr; 253(15):2219-23. PubMed ID: 2983132 [TBL] [Abstract][Full Text] [Related]
32. HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A. Shannon BT; Roach J; Cheek-Luten M; Ruymann FB Diagn Immunol; 1986; 4(1):37-42. PubMed ID: 3006971 [TBL] [Abstract][Full Text] [Related]
33. Immunologic status, granulocyte chemotaxis and antibodies to HTLVIII/LAV in haemophiliacs treated with clotting factor concentrates. Gamba G; Ippoliti G; Bajani G; Ricevuti G; Mazzone A; Badarida G; Gobbi P; Geroldi D; Ascari E Haematologica; 1987; 72(2):129-35. PubMed ID: 3040550 [No Abstract] [Full Text] [Related]
34. [Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies]. Aymard JP; Janot C; Briquel ME; André E; Schooneman F; Vigneron C; Legras B; Alexandre P; Streiff F Pathol Biol (Paris); 1985 Dec; 33(10):951-6. PubMed ID: 3005949 [TBL] [Abstract][Full Text] [Related]
35. Differential prevalence of antibody to AIDS-associated retrovirus in haemophiliacs treated with Factor VIII concentrate versus cryoprecipitate: recovery of infectious virus. Koerper MA; Kaminsky LS; Levy JA Lancet; 1985 Feb; 1(8423):275. PubMed ID: 2857339 [No Abstract] [Full Text] [Related]
36. Abnormalities of in vitro immunoglobulin production in apparently healthy haemophiliacs: relationship with alterations of T cell subsets and with HTLV-III seropositivity. Biagiotti R; Giudizi MG; Almerigogna F; Mazzetti M; Alessi A; Del Prete GF; Rafanelli D; Fiorilli M; Morfini M; Romagnani S Clin Exp Immunol; 1986 Feb; 63(2):354-8. PubMed ID: 3009063 [TBL] [Abstract][Full Text] [Related]
37. Hemophiliacs and acquired immune deficiency syndrome. Lin TA; Zhao JQ; Rabin B Chin Med J (Engl); 1985 Jun; 98(6):444-6. PubMed ID: 2996841 [No Abstract] [Full Text] [Related]
39. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic. Evatt BL; Gomperts ED; McDougal JS; Ramsey RB N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095 [TBL] [Abstract][Full Text] [Related]
40. HTLV and immunosuppression. Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]